Table 3.
Characteristic | Conducted HIV Testing 46% (N=175) |
Did Not Conduct HIV Testing 54% (N=207) |
p-value |
---|---|---|---|
Urban setting, %(n) | 61% (107) | 53% (109) | .10 |
Addiction setting, %(n) | 28% (49) | 16% (34) | .006 |
Treated >50 buprenorphine patients, %(n) | 50% (86) | 31% (63) | <0.0001 |
Percent of patients male, mean (SD) | 60% (24) | 62% (25) | .48 |
Percent of patients White, mean (SD) | 75% (29) | 82% (25) | .01 |
Percent of patients Hispanic, mean (SD) | 10% (18) | 7% (15) | .04 |
Percent of patients age 18–40 years, mean (SD) | 61% (27) | 62% (28) | .64 |
Percent uninsured, mean (SD) | 19% (29) | 17% (25) | .33 |
Percent using prescription opioids, mean (SD) | 57% (29) | 70% (30) | <.0001 |
Percent using intravenous heroin, mean (SD) | 25% (25) | 18% (28) | .005 |
Bold text indicates statistical significance at the p<0.05 level.